Derma Sciences (Nasdaq: DSCI) Soars on Buyout

Derma Sciences Inc. – Nasdaq: DSCI

Derma Sciences Inc. shares shot up over 39% on news that the company has agreed to be bought out by Integra Life Sciences (IART). Derma Sciences Inc. shares, traded on the Nasdaq under ticker DSCI, settled at $6.95 – five cents below the buyout price of $7.00.

Derma Sciences is a Tissue Regeneration Company that claims to be at the forefront of research and innovation for the management of acute and chronic wounds, and burns. Stephen Wills, executive chairman at Derma stated “”Both Integra and Derma have a significant commitment to tissue regeneration, wound care and patient care. Derma’s portfolio of biologics and advanced wound care products are a natural extension of Integra’s business, and with Integra’s global presence, our products will reach a much larger and broader set of clinicians and patients.”

I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.


Previous ArticleNext Article
James Marion is a University of Houston student studying Business with a concentration in Finance. James has interned with several investment professionals and hopes to pursue a career as a professional stock analyst after graduation.

Leave a Reply

Your email address will not be published. Required fields are marked *